‘We Wouldn’t Recommend that Any Man Take’ Finasteride, Urologist at University Hospital Zurich Tells Swiss TV News Magazine

by

‘We Wouldn’t Recommend that Any Man Take’ Finasteride, Urologist at University Hospital Zurich Tells Swiss TV News Magazine   May 20, 2018 Dear Friends: Yet another European nation has taken to the airwaves with PFS awareness. This time it’s Switzerland. The network is Swiss Radio and Television (SRF). And the program is Puls. On May

Common pathways between PFS and post-SSRI sexual dysfunction could be useful in designing therapeutic strategies for both, says new University of Milano study

by

Common pathways between PFS and post-SSRI sexual dysfunction could be useful in designing therapeutic strategies for both, says new University of Milano study   April 30, 2018 Dear Friends: Roberto Cosimo Melcangi, Ph.D., head of the Neuroendocrinology Unit in the Department of Pharmacological and Biomolecular Sciences at the University of Milano, has published a new

Leading German Paper Calls on Federal Institute for Drugs to Better Educate Doctors, Patients on PFS

by

Leading German Paper Calls on Federal Institute for Drugs to Better Educate Doctors, Patients on PFS   March 12, 2018 Dear Friends: PFS is a growing concern in Germany, too. Ditto Albania. In December, we told you that the French National Agency for Drug Safety (ANSM) launched a public-awareness campaign warning against reported mood changes

Possible Epigenetic Changes in PFS Patients is Focus of New Clinical Study

by

Possible Epigenetic Changes in PFS Patients is Focus of New Clinical Study at University of Milano   SOMERSET, N.J., Jan. 29, 2018 – The Post-Finasteride Syndrome Foundation today announced Phase II of the clinical research on post-finasteride syndrome (PFS) being conducted at the University of Milano. Led by Roberto Cosimo Melcangi, Ph.D., head of the

French Warning of Propecia-Induced Depression and Suicidal Ideation Prompts Wave of Media Attention

by

French Warning of Propecia-Induced Depression and Suicidal Ideation Prompts Wave of Media Attention   Dec. 19, 2017 Dear Friends: France is taking PFS very seriously. On Oct. 26, the French National Agency for Drug Safety (ANSM) issued a warning that “Changes in mood, particularly depression, and suicidal ideation, have been reported by patients taking Propecia.”

European Medicines Agency Recommends Adding Depression and Suicidal Ideation to Finasteride Label

by

Aug. 10, 2017 Dear Friends: On August 4, CEO John Santmann wrote in his 2017 Annual Address, “Recent events in Europe and Asia have given me hope that, before this decade is out, we’ll see the day when no man on earth is prescribed finasteride without ample warning of its many potential dangers.” Then he

2017 PFS Foundation Annual Address

by

2017 Annual Address   Aug. 4, 2017   Dear Friends: Recent events in Europe and Asia have given me hope that, before this decade is out, we’ll see the day when no man on earth is prescribed finasteride without ample warning of its many potential dangers. On May 24, the UK’s equivalent of the US

Korea Mandates Propecia Label Change Based on Reports of Depression and Suicidal Ideation

by

R E G U L A T O R Y   U P D A T E South Korea Mandates Propecia Label Change Based on Reports of Depression and Suicidal Ideation   July 15, 2017 Dear Friends: On July 4, the Korean Ministry of Food and Drug Safety (MFDS) announced it will revise the warning

MHRA Issues Drug Safety Update on Finasteride

by

MHRA Issues Drug Safety Update on Finasteride   UK surveillance agency cites reports of depression and suicidal ideation   May 26, 2017 Dear Friends: The UK’s equivalent of the US Food and Drug Administration, the Medicines and Healthcare Products Regulatory Agency (MHRA), has issued a drug safety update on finasteride. The May 24 document, titled Finasteride:

Peripheral Nervous System Involved in PFS Patients with Severe ED, New Study Demonstrates

by

Peripheral Nervous System Involved in Post-Finasteride Syndrome Patients with Severe Erectile Dysfunction, New Study Demonstrates for the First Time   SOMERSET, N.J., April 18, 2017 – Post-finasteride syndrome (PFS) patients suffer from altered levels of critical brain-function regulators, including neuroactive steroids, according to a new clinical study published in The Journal of Steroid Biochemistry and